Profile
Colin Hayward worked as Vice President-Medical Affairs at Premier Research Group Ltd. from 2013 to 2014.
Prior to that, he was a Principal at Roche Products Ltd. from 2001 to 2001 and Executive Vice President at Prism Ideas Ltd. from 2007 to 2011.
Currently, he is serving as Chief Medical Officer at Telix Pharmaceuticals Ltd. from 2020 to 2024.
Dr. Hayward holds a doctorate degree from the University of London.
Former positions of Colin Hayward
| Companies | Position | End |
|---|---|---|
| TELIX PHARMACEUTICALS LIMITED | Chief Tech/Sci/R&D Officer | 2023-12-31 |
Premier Research Group Ltd.
Premier Research Group Ltd. Miscellaneous Commercial ServicesCommercial Services Provides contract research services to pharmaceutical industry | Chief Tech/Sci/R&D Officer | 2014-02-28 |
Prism Ideas Ltd. | Corporate Officer/Principal | 2011-11-30 |
Roche Products Ltd.
Roche Products Ltd. Pharmaceuticals: MajorHealth Technology Manufactures diagnostic, diabetes and pharmaceutical products | Corporate Officer/Principal | 2001-02-28 |
Training of Colin Hayward
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Premier Research Group Ltd.
Premier Research Group Ltd. Miscellaneous Commercial ServicesCommercial Services Provides contract research services to pharmaceutical industry | Commercial Services |
University of London
University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Roche Products Ltd.
Roche Products Ltd. Pharmaceuticals: MajorHealth Technology Manufactures diagnostic, diabetes and pharmaceutical products | Health Technology |
Prism Ideas Ltd. | |
Telix Pharmaceuticals Ltd.
Telix Pharmaceuticals Ltd. BiotechnologyHealth Technology Operates as a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals | Health Technology |
- Stock Market
- Insiders
- Colin Hayward
















